Case Based Panel Discussions - 2019 ALK Pos, Developing Resistance to ALK Inhibitors and Next Steps

dbrock's picture

Submitted by dbrock on Sat, 02/29/2020 - 13:24

H. Jack West, MD, Founder, President and CEO
PDF icon Click for Printable Transcript
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.

Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.

Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.

The doctors discuss a series of cases related to a diagnosis of ALK Positive NSCLC. In this video, they discuss developing resistance to Alk inhibitors, treatment approaches and biopsies, and what are the next steps.

 

To join the conversation, visit https://cancergrace.org/forum.

Related Content: 
Case Based Panel Discussion - Unresectable NSCLC, Should Molecular Tests be Considered, and Would Outcome Effect Treatment Decisions?
Case Based Panel Discussion - Unresectable NSCLC, In a Frail Patient with Competing Risks, Is the Standard Treatment the Best Approach?
Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response
Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis
Video Language: 
English

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation